For stages I-III HR+/HER2− and HR+/HER2+ breast cancer, Asian/Pacific Islander women generally had a lower hazard of breast cancer-specific mortality than non-Hispanic White women, and this lower hazard was more pronounced among older women for HR+/HER2− breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.